Data from <i>PID1</i> (<i>NYGGF4</i>), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas Article Swipe
Anat Erdreich‐Epstein
,
Nathan Robison
,
Xiuhai Ren
,
Hong Zhou
,
Jingying Xu
,
Tom B. Davidson
,
Mathew Schur
,
Floyd H. Gilles
,
Lingyun Ji
,
Jemily Malvar
,
Gregory M. Shackleford
,
Ashley Margol
,
Mark D. Krieger
,
Alexander R. Judkins
,
David Jones
,
Stefan M. Pfister
,
Marcel Kool
,
Richard Sposto
,
Shahab Asgharazadeh
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.c.6521810.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.c.6521810.v1
Purpose: We present here the first report of PID1 (Phosphotyrosine Interaction Domain containing 1; NYGGF4) in cancer. PID1 was identified in 2006 as a gene that modulates insulin signaling and mitochondrial function in adipocytes and muscle cells.Experimental Design and Results: Using four independent medulloblastoma datasets, we show that mean PID1 mRNA levels were lower in unfavorable medulloblastomas (groups 3 and 4, and anaplastic histology) compared with favorable medulloblastomas (SHH and WNT groups, and desmoplastic/nodular histology) and with fetal cerebellum. In two large independent glioma datasets, PID1 mRNA was lower in glioblastomas (GBM), the most malignant gliomas, compared with other astrocytomas, oligodendrogliomas and nontumor brains. Neural and proneural GBM subtypes had higher PID1 mRNA compared with classical and mesenchymal GBM. Importantly, overall survival and radiation-free progression-free survival were longer in medulloblastoma patients whose tumors had higher PID1 mRNA (univariate and multivariate analyses). Higher PID1 mRNA also correlated with longer overall survival in patients with glioma and GBM. In cell culture, overexpression of PID1 inhibited colony formation in medulloblastoma, atypical teratoid rhabdoid tumor (ATRT), and GBM cell lines. Increasing PID1 also increased cell death and apoptosis, inhibited proliferation, induced mitochondrial depolaization, and decreased serum-mediated phosphorylation of AKT and ERK in medulloblastoma, ATRT, and/or GBM cell lines, whereas siRNA to PID1 diminished mitochondrial depolarization.Conclusions: These data are the first to link PID1 to cancer and suggest that PID1 may have a tumor inhibitory function in these pediatric and adult brain tumors. Clin Cancer Res; 20(4); 827–36. ©2013 AACR.
Related Topics
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.c.6521810.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361950834
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361950834Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.c.6521810.v1Digital Object Identifier
- Title
-
Data from <i>PID1</i> (<i>NYGGF4</i>), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and GliomasWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Anat Erdreich‐Epstein, Nathan Robison, Xiuhai Ren, Hong Zhou, Jingying Xu, Tom B. Davidson, Mathew Schur, Floyd H. Gilles, Lingyun Ji, Jemily Malvar, Gregory M. Shackleford, Ashley Margol, Mark D. Krieger, Alexander R. Judkins, David Jones, Stefan M. Pfister, Marcel Kool, Richard Sposto, Shahab AsgharazadehList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.c.6521810.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.c.6521810.v1Direct OA link when available
- Concepts
-
Medulloblastoma, Glioma, Biology, Internal medicine, Cancer research, Endocrinology, MedicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361950834 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.c.6521810.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.c.6521810.v1 |
| ids.openalex | https://openalex.org/W4361950834 |
| fwci | |
| type | preprint |
| title | Data from <i>PID1</i> (<i>NYGGF4</i>), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11482 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9883999824523926 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | RNA modifications and cancer |
| topics[1].id | https://openalex.org/T12820 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9883999824523926 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Chromatin Remodeling and Cancer |
| topics[2].id | https://openalex.org/T12793 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.973800003528595 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1307 |
| topics[2].subfield.display_name | Cell Biology |
| topics[2].display_name | Caveolin-1 and cellular processes |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780789225 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6924448013305664 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1333608 |
| concepts[0].display_name | Medulloblastoma |
| concepts[1].id | https://openalex.org/C2778227246 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6293417811393738 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1365309 |
| concepts[1].display_name | Glioma |
| concepts[2].id | https://openalex.org/C86803240 |
| concepts[2].level | 0 |
| concepts[2].score | 0.5078991055488586 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[2].display_name | Biology |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.38894888758659363 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3822972774505615 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C134018914 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3547890782356262 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[5].display_name | Endocrinology |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.28786206245422363 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| keywords[0].id | https://openalex.org/keywords/medulloblastoma |
| keywords[0].score | 0.6924448013305664 |
| keywords[0].display_name | Medulloblastoma |
| keywords[1].id | https://openalex.org/keywords/glioma |
| keywords[1].score | 0.6293417811393738 |
| keywords[1].display_name | Glioma |
| keywords[2].id | https://openalex.org/keywords/biology |
| keywords[2].score | 0.5078991055488586 |
| keywords[2].display_name | Biology |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.38894888758659363 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.3822972774505615 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/endocrinology |
| keywords[5].score | 0.3547890782356262 |
| keywords[5].display_name | Endocrinology |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.28786206245422363 |
| keywords[6].display_name | Medicine |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.c.6521810.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.c.6521810.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5019067908 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-4269-4373 |
| authorships[0].author.display_name | Anat Erdreich‐Epstein |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Anat Erdreich-Epstein |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5022276682 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8613-9772 |
| authorships[1].author.display_name | Nathan Robison |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nathan Robison |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5049065109 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8678-2696 |
| authorships[2].author.display_name | Xiuhai Ren |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Xiuhai Ren |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5112878209 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Hong Zhou |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hong Zhou |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5101459761 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1294-9040 |
| authorships[4].author.display_name | Jingying Xu |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jingying Xu |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5016446915 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1655-3860 |
| authorships[5].author.display_name | Tom B. Davidson |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Tom B. Davidson |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5011876489 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Mathew Schur |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mathew Schur |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5034437611 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5426-3549 |
| authorships[7].author.display_name | Floyd H. Gilles |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Floyd H. Gilles |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5013274725 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-2500-1993 |
| authorships[8].author.display_name | Lingyun Ji |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Lingyun Ji |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5060869564 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-5481-6780 |
| authorships[9].author.display_name | Jemily Malvar |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Jemily Malvar |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5047195770 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-4831-575X |
| authorships[10].author.display_name | Gregory M. Shackleford |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Gregory M. Shackleford |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5000737281 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-3038-8005 |
| authorships[11].author.display_name | Ashley Margol |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ashley S. Margol |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5046576474 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Mark D. Krieger |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Mark D. Krieger |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5040936511 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-9242-3769 |
| authorships[13].author.display_name | Alexander R. Judkins |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Alexander R. Judkins |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5100731383 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-2036-5141 |
| authorships[14].author.display_name | David Jones |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | David T.W. Jones |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5041096535 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-5447-5322 |
| authorships[15].author.display_name | Stefan M. Pfister |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Stefan M. Pfister |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5073211182 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-6557-5468 |
| authorships[16].author.display_name | Marcel Kool |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Marcel Kool |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5047701227 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-2729-2360 |
| authorships[17].author.display_name | Richard Sposto |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Richard Sposto |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5027976708 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Shahab Asgharazadeh |
| authorships[18].author_position | last |
| authorships[18].raw_author_name | Shahab Asgharazadeh |
| authorships[18].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.c.6521810.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Data from <i>PID1</i> (<i>NYGGF4</i>), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11482 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9883999824523926 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | RNA modifications and cancer |
| related_works | https://openalex.org/W1979139803, https://openalex.org/W1966504330, https://openalex.org/W2037631372, https://openalex.org/W2040058909, https://openalex.org/W2030889776, https://openalex.org/W2132898409, https://openalex.org/W2064362993, https://openalex.org/W4249176446, https://openalex.org/W1966775726, https://openalex.org/W2140569197 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.c.6521810.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.c.6521810.v1 |
| primary_location.id | doi:10.1158/1078-0432.c.6521810.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.c.6521810.v1 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.3 | 58 |
| abstract_inverted_index.a | 23, 227 |
| abstract_inverted_index.1; | 13 |
| abstract_inverted_index.4, | 60 |
| abstract_inverted_index.In | 79, 156 |
| abstract_inverted_index.We | 1 |
| abstract_inverted_index.as | 22 |
| abstract_inverted_index.in | 15, 20, 32, 54, 89, 128, 150, 165, 197, 231 |
| abstract_inverted_index.of | 7, 160, 193 |
| abstract_inverted_index.to | 206, 216, 219 |
| abstract_inverted_index.we | 45 |
| abstract_inverted_index.AKT | 194 |
| abstract_inverted_index.ERK | 196 |
| abstract_inverted_index.GBM | 107, 173, 201 |
| abstract_inverted_index.WNT | 70 |
| abstract_inverted_index.and | 29, 34, 38, 59, 61, 69, 72, 75, 101, 105, 116, 122, 138, 154, 172, 182, 189, 195, 221, 234 |
| abstract_inverted_index.are | 213 |
| abstract_inverted_index.had | 109, 133 |
| abstract_inverted_index.may | 225 |
| abstract_inverted_index.the | 4, 92, 214 |
| abstract_inverted_index.two | 80 |
| abstract_inverted_index.was | 18, 87 |
| abstract_inverted_index.(SHH | 68 |
| abstract_inverted_index.2006 | 21 |
| abstract_inverted_index.GBM. | 118, 155 |
| abstract_inverted_index.PID1 | 135, 177, 207, 218, 224 |
| abstract_inverted_index.Res; | 240 |
| abstract_inverted_index.also | 144, 178 |
| abstract_inverted_index.cell | 157, 174, 180, 202 |
| abstract_inverted_index.data | 212 |
| abstract_inverted_index.four | 41 |
| abstract_inverted_index.gene | 24 |
| abstract_inverted_index.have | 226 |
| abstract_inverted_index.here | 3 |
| abstract_inverted_index.link | 217 |
| abstract_inverted_index.mRNA | 50, 86, 112, 136, 143 |
| abstract_inverted_index.mean | 48 |
| abstract_inverted_index.most | 93 |
| abstract_inverted_index.show | 46 |
| abstract_inverted_index.that | 25, 47, 223 |
| abstract_inverted_index.were | 52, 126 |
| abstract_inverted_index.with | 65, 76, 97, 114, 146, 152 |
| abstract_inverted_index.ATRT, | 199 |
| abstract_inverted_index.These | 211 |
| abstract_inverted_index.Using | 40 |
| abstract_inverted_index.adult | 235 |
| abstract_inverted_index.brain | 236 |
| abstract_inverted_index.death | 181 |
| abstract_inverted_index.fetal | 77 |
| abstract_inverted_index.first | 5, 215 |
| abstract_inverted_index.large | 81 |
| abstract_inverted_index.lower | 53, 88 |
| abstract_inverted_index.other | 98 |
| abstract_inverted_index.siRNA | 205 |
| abstract_inverted_index.these | 232 |
| abstract_inverted_index.tumor | 170, 228 |
| abstract_inverted_index.whose | 131 |
| abstract_inverted_index.(GBM), | 91 |
| abstract_inverted_index.20(4); | 241 |
| abstract_inverted_index.Cancer | 239 |
| abstract_inverted_index.Design | 37 |
| abstract_inverted_index.Higher | 141 |
| abstract_inverted_index.Neural | 104 |
| abstract_inverted_index.and/or | 200 |
| abstract_inverted_index.cancer | 220 |
| abstract_inverted_index.colony | 163 |
| abstract_inverted_index.glioma | 83, 153 |
| abstract_inverted_index.higher | 110, 134 |
| abstract_inverted_index.levels | 51 |
| abstract_inverted_index.lines, | 203 |
| abstract_inverted_index.lines. | 175 |
| abstract_inverted_index.longer | 127, 147 |
| abstract_inverted_index.muscle | 35 |
| abstract_inverted_index.report | 6 |
| abstract_inverted_index.tumors | 132 |
| abstract_inverted_index.©2013 | 243 |
| abstract_inverted_index.(ATRT), | 171 |
| abstract_inverted_index.(groups | 57 |
| abstract_inverted_index.NYGGF4) | 14 |
| abstract_inverted_index.brains. | 103 |
| abstract_inverted_index.cancer. | 16 |
| abstract_inverted_index.groups, | 71 |
| abstract_inverted_index.induced | 186 |
| abstract_inverted_index.insulin | 27 |
| abstract_inverted_index.overall | 120, 148 |
| abstract_inverted_index.present | 2 |
| abstract_inverted_index.suggest | 222 |
| abstract_inverted_index.tumors. | 237 |
| abstract_inverted_index.whereas | 204 |
| abstract_inverted_index.atypical | 167 |
| abstract_inverted_index.compared | 64, 96, 113 |
| abstract_inverted_index.culture, | 158 |
| abstract_inverted_index.function | 31, 230 |
| abstract_inverted_index.gliomas, | 95 |
| abstract_inverted_index.nontumor | 102 |
| abstract_inverted_index.patients | 130, 151 |
| abstract_inverted_index.rhabdoid | 169 |
| abstract_inverted_index.subtypes | 108 |
| abstract_inverted_index.survival | 121, 125, 149 |
| abstract_inverted_index.teratoid | 168 |
| abstract_inverted_index.827–36. | 242 |
| abstract_inverted_index.classical | 115 |
| abstract_inverted_index.datasets, | 44, 84 |
| abstract_inverted_index.decreased | 190 |
| abstract_inverted_index.favorable | 66 |
| abstract_inverted_index.formation | 164 |
| abstract_inverted_index.increased | 179 |
| abstract_inverted_index.inhibited | 162, 184 |
| abstract_inverted_index.malignant | 94 |
| abstract_inverted_index.modulates | 26 |
| abstract_inverted_index.pediatric | 233 |
| abstract_inverted_index.proneural | 106 |
| abstract_inverted_index.signaling | 28 |
| abstract_inverted_index.Increasing | 176 |
| abstract_inverted_index.adipocytes | 33 |
| abstract_inverted_index.analyses). | 140 |
| abstract_inverted_index.anaplastic | 62 |
| abstract_inverted_index.apoptosis, | 183 |
| abstract_inverted_index.containing | 12 |
| abstract_inverted_index.correlated | 145 |
| abstract_inverted_index.diminished | 208 |
| abstract_inverted_index.histology) | 63, 74 |
| abstract_inverted_index.identified | 19 |
| abstract_inverted_index.inhibitory | 229 |
| abstract_inverted_index.(univariate | 137 |
| abstract_inverted_index.cerebellum. | 78 |
| abstract_inverted_index.independent | 42, 82 |
| abstract_inverted_index.mesenchymal | 117 |
| abstract_inverted_index.unfavorable | 55 |
| abstract_inverted_index.Importantly, | 119 |
| abstract_inverted_index.multivariate | 139 |
| abstract_inverted_index.<i>Clin | 238 |
| abstract_inverted_index.astrocytomas, | 99 |
| abstract_inverted_index.glioblastomas | 90 |
| abstract_inverted_index.mitochondrial | 30, 187, 209 |
| abstract_inverted_index.depolaization, | 188 |
| abstract_inverted_index.overexpression | 159 |
| abstract_inverted_index.proliferation, | 185 |
| abstract_inverted_index.radiation-free | 123 |
| abstract_inverted_index.serum-mediated | 191 |
| abstract_inverted_index.medulloblastoma | 43, 129 |
| abstract_inverted_index.phosphorylation | 192 |
| abstract_inverted_index.medulloblastoma, | 166, 198 |
| abstract_inverted_index.medulloblastomas | 56, 67 |
| abstract_inverted_index.progression-free | 124 |
| abstract_inverted_index.Results:</b> | 39 |
| abstract_inverted_index.oligodendrogliomas | 100 |
| abstract_inverted_index.desmoplastic/nodular | 73 |
| abstract_inverted_index.<i>PID1</i> | 8, 17, 49, 85, 111, 142, 161 |
| abstract_inverted_index.<i>D</i>omain | 11 |
| abstract_inverted_index.<i>I</i>nteraction | 10 |
| abstract_inverted_index.(<i>P</i>hosphotyrosine | 9 |
| abstract_inverted_index.AACR</i>.</p></div> | 244 |
| abstract_inverted_index.cells.</p><p><b>Experimental | 36 |
| abstract_inverted_index.<div>Abstract<p><b>Purpose:</b> | 0 |
| abstract_inverted_index.depolarization.</p><p><b>Conclusions:</b> | 210 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 19 |
| citation_normalized_percentile.value | 0.12507646 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |